Navigation Links
SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
Date:6/25/2008

SciQuest Solution Enables Enhanced Productivity and Decreased Expenses

CARY, N.C., June 25 /PRNewswire/ -- SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that BioMarin Pharmaceutical Inc., a leading biopharmaceutical research and development firm, has chosen the SciQuest eprocurement platform to streamline and enhance procurement functions for its operations in Novato, Calif.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, delivering first-to-market therapeutic treatments to patients with rare genetic disorders. The company's portfolio comprises three FDA-approved products and multiple clinical and preclinical product candidates.

"SciQuest's solution is extremely intuitive and allows our employees to manage and acquire their own materials and supplies quickly and easily," said Isaac Young, director of Supply Chain Operations for BioMarin. "This allows our employees to be more efficient and allows them to focus their efforts on our core business activities."

BioMarin uses SciQuest's SelectSite(TM) Express platform to maximize procurement cost savings and streamline the procurement process. SciQuest provides clear visibility into the progress of BioMarin's purchases through each step of the approval process. SciQuest then seamlessly integrates with BioMarin's ERP infrastructure for accounting and order tracking purposes.

For BioMarin, SciQuest's clear and demonstrated ROI, coupled with its industry-leading easy-to-use interface made it the solution of choice for its employees to handle their own procurement needs.

"SciQuest enables life sciences organizations to perform more effectively by ensuring that staff can quickly procure essential materials so that they can remain focused on developing new treatments," said Stephen Wiehe, president an
'/>"/>

SOURCE SciQuest, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
2. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
3. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
4. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 Veracyte, Inc. ... H. Anderson , president and chief executive officer, will ... Wednesday, September 16, 2015 at 10:30 a.m. ET in ... The live audio webcast and subsequent replay may ... webcast will be available shortly after conclusion of the ...
(Date:9/2/2015)... September 2, 2015 Biovista ... Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. Hierbei ... Genomics Institute. Biovista unterstützt mit seiner ... die Behandlung anderer Krankheiten als denen, für die ... und sein Team bei der Wylder Nation ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry ... their entire waste to energy process and continue to contribute to the sustainability ... , Temarry’s Waste to Energy process has been operating at their Mexico facility, ...
(Date:9/1/2015)... 2015 Swecure, ein ... und Entwicklung neuartiger Therapien für Störungen des ... Reizdarm konzentriert, erhält vom US Patent and ... Medikament patentiert wird. Das Medikament basiert auf ... verhindert und Entzündungen vorbeugt.   Das ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
... Breakthrough biotechnology research is providing new applications ... and diabetes, two leading health concerns among consumers. ... Advana Science, www.advanascience.com , will ... this dynamic consumer healthy category at VitaFoods International ...
... Development Candidate Triggers Milestone Payment from GlaxoSmithKlineMOUNTAIN VIEW, ... that it has identified an orally bioavailable small ... a candidate for clinical development. The acceptance ... a $5.0 million milestone payment from the alliance ...
... May 5 Poniard Pharmaceuticals, Inc. (Nasdaq: ... Committee (DMC), after review of available information regarding the ... the SPEAR (Study of Picoplatin Efficacy After Relapse) trial ... the efficacy and safety of picoplatin in patients with ...
Cached Biology Technology:Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 3ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 3Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 5
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/18/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ) has ... Authentication & Identification Market: Focus On Modality, Motility ... report to their offering. The ... expected to grow at an estimated CAGR of ... $25 billion (approximately) by 2020 as per the ...
(Date:8/12/2015)... August 12, 2015 As the ... payment innovation and advanced biometrics technology is accelerating beyond ... consumers rely on using their credit cards, the digital ... future for payment services led by companies in the ... :  Google, Inc. (NASDAQ: GOOG ), Apple Inc. ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... replaced a single atom from the molecular structure of ... by inhibiting cell wall synthesis, significantly increasing the drug's ... the most common strains of enterococci have become resistant ... under scrutiny. This re-engineering effort could help make the ...
... that has puzzled researchers for many years has been explained ... maintaining the balance of carbon in the Earth's atmosphere require ... mystery to scientists why some types needed external sources and ... and Kent have discovered that half of all algae have ...
... is among one of the most exciting and hotly ... promise of personalized medicine and effective treatments for debilitating ... dilemmas about embryonic cells continues to cloud the field. ... of Cardiology's 55th Annual Scientific Session, scientists continue to ...
Cached Biology News:Scientists re-engineer a well-known antibiotic to counter drug resistance 2The secret life of algae 2Potential heart benefit found in stem cells 2Potential heart benefit found in stem cells 3Potential heart benefit found in stem cells 4Potential heart benefit found in stem cells 5